W

Waterstone Pharmaceuticals, Inc.

21 employees

Waterstone Pharmaceuticals is engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

custom synthesis

- Catalog of research products

and cGMP intermediates and APIs meeting ICH Q7 and US FDA guidelines

Health Care

2008

$3.4M

from 2 investors over 2 rounds

W

Waterstone Pharmaceuticals, Inc. raised $3.4M on August 21, 2012

Investors: ACORN CAMPUS, L.L.C. and -